News
Latest news
ADARx Announces Oversubscribed $200 Million Series C Financing

ADARx Pharmaceuticals

August 09 2023
CG Oncology Announces $105 Million Oversubscribed Crossover Financing to Support Continued Advancement of Clinical-Stage Bladder Cancer Pipeline

CG Oncology

August 02 2023
ArriVent Closes $155 Million Oversubscribed Series B Financing

Arrivent Biopharma

March 27 2023
ADARx Raises $46 Million as Lead Product Enters the Clinic

ADARx Pharmaceuticals

January 20 2023
CG Oncology Raises $120 Million in Oversubscribed Series E Financing to Advance Clinical-Stage Urologic Oncology Pipeline

CG Oncology

November 15 2022
ADARx Raises $75 Million to Advance Growing Pipeline

ADARx Pharmaceuticals

September 08 2021

Get In Touch

Contact Us